Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy’s ability to improve patients’ mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness.

April 27, 2026—You may think of the high-fat, low-carb eating plan as a faddish way to lose weight. But the keto diet is now being used to tackle conditions from severe depression to bipolar disorder and anorexia, with transformative results.